Melanoma

3 researchers across 1 institution

3 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Researchers investigate the fundamental biology of melanoma, a significant form of skin cancer. Studies focus on understanding the molecular mechanisms that drive melanoma development, progression, and metastasis. This includes examining genetic mutations, cellular signaling pathways, and the tumor microenvironment. Investigations also explore the development and application of novel therapeutic strategies, including drug delivery systems and the use of nanoparticles and lasers for treatment. Research employs various experimental models to identify new targets and test potential interventions.

Melanoma research holds relevance for Arkansas by addressing public health concerns related to skin cancer incidence and mortality. Understanding the disease's mechanisms can inform prevention strategies and improve treatment outcomes for Arkansans. The work also connects to the state's bioscience and healthcare sectors, fostering innovation in diagnostic tools and therapeutic development. Investigating new treatment modalities may lead to advancements that benefit patients statewide.

This area of study involves collaboration with experts in cancer biology, molecular genetics, pharmacology, and biomedical engineering. Research efforts leverage expertise across multiple institutions, drawing on diverse perspectives to advance the understanding and treatment of melanoma.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Stephen R. Foster UAMS 12 667 Faculty
Alex Lagasse UAMS 5 86
Billie Heflin UAMS 4 77

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
1 works in 2031
-46.7% CAGR 2018–2031
Leadership concentration
7.1% held by global top 5 institutions
Fragmented HHI 32
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2031 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 1,989
  2. 2 Harvard University 1,500
  3. 3 Massachusetts General Hospital 1,335
  4. 4 Memorial Sloan Kettering Cancer Center 1,316
  5. 5 Dana-Farber Cancer Institute 1,018
Browse All 3 Researchers in Directory